An interventional study of sodium oxybate and Placebo in Thoracic Surgical Procedures, sponsored by Jingsheng Lou. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Jingsheng Lou · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a single-center, randomized, double-blind, placebo-controlled trial. Three hundred-sixty adult patients undergoing elective thoracoscopic surgery will be randomly allocated at a 1:1 ratio to receive either intraoperative sodium oxybate or placebo. The primary objective is to compare postoperative sleep quality between the two groups. Secondary outcomes include postoperative pain scores, incidence of adverse events and other peri-operative indicators.
Postoperative sleep disturbance is common after thoracoscopic surgery, which may aggravate pain response and impair postoperative recovery. Sodium oxybate is a sedative-hypnotic agent. This trial intends to explore whether intraoperative administration of sodium oxybate can improve postoperative sleep quality in surgical patients, and to evaluate its peri-operative safety.
This is the only study on the registry with Jingsheng Lou as lead sponsor.
Counted across the registry records on this site, refreshed daily.
The criteria were revised on the registry on Oct 20, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intravenous sodium oxybate administered during general anesthesia
Drug: sodium oxybate
Intravenous placebo administered during general anesthesia
Drug: Placebo
Intravenous administration during general anesthesia
Intravenous administration during general anesthesia
Subjective sleep quality on Post-Operative Day 1 (POD1)
Subjective sleep quality on Post-Operative Day 1 (POD1), measured by the Richards-Campbell Sleep Questionnaire (RCSQ) total score. The RCSQ total score is the mean value of the first 5 items, ranging from 0 to 100. Higher scores indicate better subjective sleep quality.
Time frame: Morning of Post-Operative Day 1 (POD1)
Sleep efficiency (SE%)
Sleep efficiency (SE%) derived from wrist-worn actigraphy.
Time frame: First Post-Operative Night
Total sleep time (TST, minutes)
Total sleep time (TST, minutes) derived from wrist-worn actigraphy.
Time frame: First Post-Operative Night
Wake After Sleep Onset (WASO, minutes)
Wake After Sleep Onset (WASO, minutes) derived from wrist-worn actigraphy.
Time frame: First Post-Operative Night
Sleep Latency (SL, minutes)
Sleep Latency (SL, minutes) derived from wrist-worn actigraphy.
Time frame: First Post-Operative Night
Incidence and severity of postoperative delirium
Incidence and severity of postoperative delirium assessed by the 3-Minute Diagnostic Interview for Confusion Assessment Method-Defined Delirium (3D-CAM). This tool yields a binary diagnosis of delirium (present or absent), as well as grading for delirium severity.
Time frame: Twice daily (Morning 08:00-10:00 and Evening 18:00-20:00), covering Post-Operative Day 1 (POD1), Post-Operative Day 2 (POD2), Post-Operative Day 3 (POD3)
Total intraoperative consumption of anesthetic agents
Cumulative intraoperative consumption of propofol and remifentanil.
Time frame: Intraoperative period
Post-operative Quality of Recovery-15 (QoR-15) score
Post-operative recovery quality assessed by the Post-operative Quality of Recovery-15 (QoR-15) questionnaire. The total score ranges from 0 to 150. Higher scores indicate better postoperative recovery quality.
Time frame: Morning of Post-Operative Day 3 (POD3)
Incidence of peri-operative adverse events
From study drug administration to hospital discharge, up to POD7 Description: Postoperative nausea and vomiting (PONV); respiratory depression (SpO2 \<90% lasting \>2 min); delayed emergence (Steward recovery score \<4 lasting \>30 min post-extubation); bradycardia (HR \<50 bpm); hypothermia (core temp \<35.5℃); electrolyte disorders (hypokalemia, hyponatremia); and Serious Adverse Events (SAEs).
Time frame: Incidence of peri-operative adverse events
Intra-operative core body temperature
Intra-operative core body temperature measured during surgery.
Time frame: From completion of endotracheal intubation until the end of surgical procedure
Incidence and severity of post-anesthetic shivering
Incidence and severity grading of post-anesthetic shivering.
Time frame: From the end of surgical procedure until prior to ward transfer
Fasting blood glucose
Peripheral fasting blood glucose concentration.
Time frame: Baseline (morning on the day of surgery), morning of Post-Operative Day 1 (POD1))
Blood lactate
Peripheral blood lactate concentration.
Time frame: Baseline (morning on the day surgery, fasting state), morning of Post-Operative Day 1 (POD1)
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for Dec 2027, 15 months after the start.
Start moved once since we started tracking on Sep 25, 2026: Aug 2026 → Sep 2026, on Oct 20, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Sodium Oxybate